AI Science Tracker
EN

Epigenetics and Diabetes Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Lund University, 205 02, Malmö, Sweden

1 discovery from 2024

Discoveries

Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: DIABLO/PLS multi-omics integration predicted type 2 diabetes status and identified associated biomarkers in a small cross-sectional donor sample; independent clinical validation was not established.

Technology: DIABLO/PLS multi-omics integration

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
DIABLO/PLS multi-omics integration
Limitation / still unknown
The result came from a small cross-sectional donor sample; independent diagnostic performance and prospective clinical utility were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38918439 · https://doi.org/10.1038/s41598-024-64846-3 · https://pubmed.ncbi.nlm.nih.gov/38918439/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.